Professor Thomas Giddens is Chair of Jurisprudence in Dundee Law School. Taking its cues from the humanities heritage of the legal discipline, Prof Giddens’s research focuses on critical and cultural ...
Our research aims to support and enhance social science-led collaboration across interdisciplinary research themes. Here are a few examples of recent collaborative research projects.
Scientists at the University of Dundee have made a significant breakthrough in the quest to eradicate a parasite that blights millions of lives.
Professor Lady Sue Black, Baroness of Strome, is making a return to the University of Dundee to deliver this year’s Margaret ...
The Discovery Centre (for Translational and Interdisciplinary Research) was opened on October 1st 2014 by Sir Paul Nurse, then Director of the Francis Crick Institute and President of the Royal ...
Wilson Ngotho graduated from the LLM Environmental Law programme in 2024. This specialist LLM covers the structures, principles, and institutions of environmental law both at domestic and ...
In 2024, Professor Paul Birch of the University of Dundee at the James Hutton Institute was nominated for the BSPP RKS Wood Prize by Dr Ingo Hein and Professor Richard Oliver. The BSPP were pleased to ...
The Drug Discovery Unit (DDU) initiated collaboration this summer on two projects with the Biomedical Research division of Novartis and is extremely proud of this joint effort to drive forward new ...
When I decided to pursue my master’s degree in International Marketing, I wanted more than just a traditional classroom experience. I sought a program that would offer flexibility, real-world ...
Graham Shapiro, a British inventor, designer, and digital entrepreneur, brings a wealth of experience and an exceptional innovation and leadership track record to the school. Graham is widely ...
Everyone is so nice, like really nice. It was unexpected. It's one of the most welcoming cities in the UK. How friendly people are and how willing they are to help you. They want to see you do well.
LRRK2 Investigative Therapeutics Exchange (LITE) will support new approaches targeting LRRK2, the most common cause of inherited Parkinson’s disease Programme to focus on bridging basic science ...